Lidocain Egis

Lidocaine, the active ingredient in Lidocain Egis, is a local anesthetic presented as a topical preparation for skin application. It produces reversible blockade of voltage‑gated sodium channels, resulting in temporary loss of sensation. The product is used to alleviate pain, reduce itching, and provide local anesthesia for minor dermatological procedures in adults.

GNH USA supplies Lidocain Egis as a licensed, Good Distribution Practice‑compliant international pharmaceutical supplier, delivering the product to hospitals, pharmacies and clinics across global markets with established quality assurance and regulatory support.

Lidocain Egis, a topical lidocaine formulation, is employed for local anesthetic and antipruritic purposes on the skin.

Local anesthesia of skin: provides temporary loss of sensation to facilitate minor surgical or diagnostic procedures. Pain relief: reduces superficial pain associated with minor injuries, burns or abrasions. Pruritus relief: alleviates itching caused by dermatological conditions such as eczema or insect bites.

Topical lidocaine may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Skin irritation: redness, burning or stinging at the application site. - Mild itching: transient pruritus near the treated area. - Transient numbness: temporary loss of sensation beyond the intended area. - Allergic contact dermatitis: localized rash in sensitized individuals.

Serious or Rare Side Effects: - Systemic toxicity: dizziness, tinnitus, seizures or cardiac arrhythmias with excessive absorption. - Severe allergic reaction: angioedema, swelling of the face or throat, or anaphylaxis. - Methemoglobinemia: rare blood disorder presenting with cyanosis and shortness of breath.

When using Lidocain Egis, consider the following precautions to ensure safe and effective application.

Application area: limit use to intact skin and avoid mucous membranes. Quantity: do not exceed the recommended amount to prevent systemic absorption. Age: use with caution in pediatric patients; consult a healthcare professional. Concomitant medications: avoid simultaneous use with other local anesthetics or agents that may increase lidocaine levels. Medical conditions: assess for cardiac, hepatic or renal impairment before use. Store at room temperature: keep below 25°C, protect from moisture and direct sunlight.

Lidocain Egis can interact with certain drugs, altering its safety profile or efficacy.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase risk of cardiac toxicity. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise systemic lidocaine concentrations.

Moderate Interactions (Monitor Closely): - Other local anesthetics: additive effect on nerve block, monitor total dose. - Beta‑blockers: may potentiate cardiovascular effects of lidocaine. - Diuretics (e.g., furosemide): may reduce plasma protein binding, increasing free lidocaine.